Cargando…

1058. Prognostic Biomarkers for Persistent Bacteremia and Mortality in Complicated S. aureus Bloodstream Infection

BACKGROUND: Staphylococcus aureus is a leading cause of bacteremia, yet there remains a significant knowledge gap in the identification of relevant biomarkers that predict clinical outcomes in patients with S. aureus bacteremia. Heterogeneity in the host response to invasive S. aureus infection sugg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Yi, Guimaraes, Alessander, Hong, Kyu, Mayba, Oleg, Peck, Melicent, Gutierrez, Johnny, Ruffin, Felicia, Carrasco-Triguero, Montserrat, Dinoso, Jason, Clemenzi-Allen, A Asa, Koss, Catherine, Maskarinec, Stacey A, Chambers, Henry F, Fowler Jr., Vance G, Baruch, Amos, Rosenberger, Carrie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253171/ http://dx.doi.org/10.1093/ofid/ofy210.895

Ejemplares similares

Prognostic Power of Pathogen Cell-Free DNA in Staphylococcus aureus Bacteremia
por: Guimaraes, Alessander O, et al.
Publicado: (2019)

Risk stratification biomarkers for Staphylococcus aureus bacteraemia
por: Cao, Yi, et al.
Publicado: (2020)

Sustained Circulating Bacterial Deoxyribonucleic Acid Is Associated With Complicated Staphylococcus aureus Bacteremia
por: Gutierrez, Johnny, et al.
Publicado: (2019)

1054. Biofilm Formation Among Escherichia coli Bloodstream Infection Isolates Is Associated With Source of Bacteremia and Bacterial Sequence Type
por: Chang, Carolyn, et al.
Publicado: (2018)

960. Clinical impact of follow-up blood cultures in gram-negative bloodstream infections: A validation cohort
por: Thaden, Joshua T, et al.
Publicado: (2023)

1039. Surveillance Blood Cultures Associated With Decreased Mortality in Gram-Negative Bacteremia
por: Maskarinec, Stacey A, et al.
Publicado: (2018)

59. Risk Factors for Recurrent Gram-Negative Bacterial Bloodstream Infections
por: Bock, Andrew J, et al.
Publicado: (2021)

167. A Phase 1b, Randomized, Double-blind, Placebo-controlled, Multiple-ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Patients with staphylococcus Aureus Bacteremia Receiving Standard-of-care Antibiotics
por: Lim, Jeremy, et al.
Publicado: (2020)

216. Bacterial Genotype and Clinical Outcomes in Solid Organ Transplant Recipients with Staphylococcus aureus Bacteremia
por: Eichenberger, Emily, et al.
Publicado: (2021)

156. Clinical Characteristics and Acute-phase Cytokine Response of Solid-Organ Transplant Recipients with Bloodstream Infections Differs According to Bacterial Type and Transplant Status
por: Eichenberger, Emily, et al.
Publicado: (2019)

181. Demographic and Geographic Epidemiology of Staphylococcus aureus Bacteremia using Geographic Information Systems Mapping and Spatial Statistics
por: Marshall, Julia, et al.
Publicado: (2021)

Association of Follow-up Blood Cultures With Mortality in Patients With Gram-Negative Bloodstream Infections: A Systematic Review and Meta-analysis
por: Thaden, Joshua T., et al.
Publicado: (2022)

240. Transcriptional signatures differentiate pathogen- and treatment-specific host responses in patients with bacterial bloodstream infections
por: Thaden, Joshua T, et al.
Publicado: (2023)

1305. Comparison of Pharmacokinetics of DSTA4637S, a novel THIOMAB(TM) Antibody-Antibiotic Conjugate, in Patients with Staphylococcus aureus Bacteremia Receiving Standard-of-Care Antibiotics with Pharmacokinetics in Healthy Volunteers
por: Rymut, Sharon M, et al.
Publicado: (2020)

Pharmacokinetics and pharmacodynamics of DSTA4637A: A novel THIOMAB™ antibody antibiotic conjugate against Staphylococcus aureus in mice
por: Zhou, Chenguang, et al.
Publicado: (2016)

Understanding heterogeneity in the host response to Staphylococcus aureus infection for prognostic biomarker discovery
por: Dinoso, JB, et al.
Publicado: (2014)

The Risk of Cardiac Device-Related Infection in Bacteremic Patients Is Species Specific: Results of a 12-Year Prospective Cohort
por: Maskarinec, Stacey A, et al.
Publicado: (2017)

189. Risk Factors and Outcomes of Hematogenous Vertebral Osteomyelitis in Patients with staphylococcus Aureus Bacteremia: Results from a 20-year Prospective Cohort
por: Dagher, Michael M, et al.
Publicado: (2020)

1060. Risk Factors for Recurrent Staphylococcus aureus Bacteremia
por: Choi, Seong-Ho, et al.
Publicado: (2018)

Complement levels in patients with bloodstream infection due to Staphylococcus aureus or Gram-negative bacteria
por: Eichenberger, Emily M., et al.
Publicado: (2020)

1030. Association of Female Sex with Mortality in Patients with Staphylococcus aureus Bacteremia: a Systematic Review and Meta-analysis
por: Westgeest, Annette C, et al.
Publicado: (2023)

1373. Racial Disparities in Clinical Characteristics and Outcomes for Methicillin Susceptible and Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Mohnasky, Michael C, et al.
Publicado: (2021)

637. Whole-Genome Sequencing (WGS) of Isolates from Resolving (RB) and Persistent (PB) Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Sharma-Kuinkel, Batu K, et al.
Publicado: (2019)

Direct Detection and Quantification of Bacterial Cell-free DNA in Patients with Bloodstream Infection (BSI) Using the Karius Plasma Next Generation Sequencing (NGS) Test
por: Wanda, Lisa, et al.
Publicado: (2017)

Complicated Staphylococcus aureus Bacteremia (SAB) Is Associated with Genetic Variation in GLS2
por: Fowler, Vance, et al.
Publicado: (2017)

307. Exploring HLA genotypes as contributing risk factors in Staphylococcus aureus bacteremia
por: Tao, Yazhong, et al.
Publicado: (2023)

224. Clinical Relevance of Antibiotic Tolerance in Recurrent Gram-negative Bloodstream Infections
por: Parsons, Joshua B, et al.
Publicado: (2023)

1058. In Vitro and In Vivo Antibacterial Activity of Cefiderocol against Burkholderia spp
por: Oota, Merime, et al.
Publicado: (2021)

Evaluating genetic susceptibility to Staphylococcus aureus bacteremia in African Americans using admixture mapping
por: Cyr, D D, et al.
Publicado: (2017)

Global Differences in the Management of Staphylococcus aureus Bacteremia: No International Standard of Care
por: Westgeest, Annette C, et al.
Publicado: (2023)

PO-1058 Estimating the carbon footprint of the radiotherapy pathway and changes in response to COVID-19
por: Cummings, J., et al.
Publicado: (2022)

727 Evaluating the Impact of Socioeconomic Status on Clinical Presentation in Patients with Staphylococcus aureus Bacteremia
por: Clemenzi-Allen, Angelo, et al.
Publicado: (2014)

PG1058 Is a Novel Multidomain Protein Component of the Bacterial Type IX Secretion System
por: Heath, Jacqueline E., et al.
Publicado: (2016)

Esophageal foreign body ingestion in adults on weekdays and holidays: A retrospective study of 1058 patients
por: Zhong, Qian, et al.
Publicado: (2017)

Polymorphisms in Fibronectin Binding Proteins A and B among Staphylococcus aureus Bloodstream Isolates Are Not Associated with Arthroplasty Infection
por: Eichenberger, Emily M., et al.
Publicado: (2015)

A genome-wide association study of variants associated with acquisition of Staphylococcus aureus bacteremia in a healthcare setting
por: Nelson, Charlotte L, et al.
Publicado: (2014)

Exploration of pre‐hospital patient delays in seeking care for symptoms of bacteremia and sepsis: A qualitative study
por: Ruffin, Felicia, et al.
Publicado: (2022)

Genetic variation of DNA methyltransferase-3A contributes to protection against persistent MRSA bacteremia in patients
por: Mba Medie, Felix, et al.
Publicado: (2019)

1058. Demographics of Hepatitis C Virus Antibody and RNA Positivity within an Emergency Department Screening Program
por: Segal, Talia A, et al.
Publicado: (2020)

P1058: REAL-WORLD OUTCOMES WITH FEDRATINIB THERAPY IN PATIENTS WITH PRIMARY MYELOFIBROSIS POST-RUXOLITINIB DISCONTINUATION
por: Passamonti, F., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ha2tgigsjv1e4tk2cjlblf9q8o